Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
antibody drugs
Biotech
Leads Biolabs hits Hong Kong stock exchange in $189M IPO
The Nanjing-based antibody aficionado plans to use the windfall first and foremost on clinical trials.
Darren Incorvaia
Jul 25, 2025 10:59am
Sino Biopharm buys Merck’s PD-1xVEGF bispecific partner LaNova
Jul 15, 2025 10:16am
Biocon accused of IP theft to create cancer biotech Bicara
Oct 24, 2024 11:04am
AstraZeneca preps new COVID push after antibody's ph. 3 success
May 16, 2024 7:15am
Charles River Labs partners with Wheeler Bio for CMC platform
Feb 26, 2024 3:15pm
Disco gets down with €20M to find targets for cancer therapy
Jan 16, 2024 3:30am
